Skip to content
HUB Organoids
services
services overview
drug screening
model and assay development
clinical trials in a dish
technology
company
about us
careers
events
latest news
resources
license program
contact
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
NPJ Precis Oncol | April 2021
X
Have any questions?
